On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...

Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...

WHO Prequalification approval allows Abbott ( <a href="http://www.Abbott.com" id="59c52bdb-d8e4-395f-aca5-b1ec1e14bb1c"> www.Abbott.com </a> ) to bring critical ...

INDIANAPOLIS, (WISH) – The holidays are about spreading joy, but it’s also a time when celebrating with friends and family can get us sick. On Tuesday, Dr. Mary Rodgers, a Ph.D. who is an Abbott ...

Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in diagnostics, which accelerated in the third quarter. Third-quarter revenue for its ...

Abbott has integrated its Precision Oncology portfolio into Flatiron Health’s OncoEMR platform, enabling oncologists to order and receive test results directly within their clinical workflow. The move ...

By Siddhi Mahatole and Puyaan Singh April 16 (Reuters) - Abbott cut its annual profit forecast on Thursday due to an impact ...

WASHINGTON (AP) — The Food and Drug Administration said Wednesday that Abbott Laboratories is recalling up to 359 million testing strips used by diabetics because they can give falsely low blood sugar ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...